Physician profile
Anthony Mcclafferty
NPI 1871021758
$1,370.47
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $213 · 2022: $692 · 2023: $339 · 2024: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $367 · Education: $98.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $366.85 |
| Education | $98.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $520.18 | 2021-2023 | Ensite |
| Boston Scientific Corporation | $250.43 | 2022-2024 | Avvigo Guidance System |
| Biosense Webster, INC. | $199.52 | 2023-2024 | Na, Carto 3 |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 | |
| Angiodynamics, INC. | $80.66 | 2024 | Alphavac |
| Edwards Lifesciences Corporation | $72.65 | 2022 | |
| Philips North America LLC | $52.85 | 2022 | |
| Terumo Medical Corporation | $49.18 | 2023 | Glidewire, Tr Band |
| Chiesi USA, INC. | $20.00 | 2023 | Kengreal, Cleviprex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Mcclafferty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.